System, Endovascular Graft, Aortic Aneurysm Treatment
Basic Information
- Device Name
- System, Endovascular Graft, Aortic Aneurysm Treatment
- Trade Name
- ENDURANT IIS STENT GRAFT SYSTEM
- PMA Number
- P100021
- Supplement Number
- S039
- Device Class
- FDA Class 3
- Product Code
- MIH
- Generic Name
- SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- October 23, 2014
- Date Received
- July 25, 2014
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
APPROVAL FOR THE ADDITION OF FIVE (5) SHORT BIFURCATED STENT GRAFT CONFIGURATIONS TO THE ENDURANT II STENT GRAFT SYSTEM, WHICH ARE CALLED ENDURANT IIS STENT GRAFTS (ALSO REFERRED TO AS ENDURANT IIS). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME ENDURANT IIS STENT GRAFT SYSTEM. THE ENDURANT II/ENDURANT IIS BIFURCATED STENT GRAFTS ARE INDICATED FOR THE ENDOVASCULAR TREATMENT OF INFRARENAL ABDOMINAL AORTIC OR AORTOILIAC ANEURYSMS. THE ENDURANT II AORTO-UNI-ILIAC (AUI) STENT GRAFT IS INDICATED FOR THE ENDOVASCULAR TREATMENT OF INFRARENAL ABDOMINAL AORTIC OR AORTOILIAC ANEURYSMS IN PATIENTS WHOSE ANATOMY DOES NOT ALLOW THE USE OF BIFURCATED STENT GRAFT. THE ENDURANT II/ENDURANT IIS STENT GRAFT SYSTEM IS INDICATED FOR USE IN PATIENTS WITH THE FOLLOWING CHARACTERISTICS:1) ADEQUATE ILIAC OR FEMORAL ACCESS THAT IS COMPATIBLE WITH VASCULAR ACCESS TECHNIQUES, DEVICES OR ACCESSORIES; 2) PROXIMAL NECK LENGTH >=10 MM;3) INFRARENAL NECK ANGULATION <=60°;4) AORTIC NECK DIAMETERS WITH A RANGE OF 19 TO 32 MM; 5) DISTAL FIXATION LENGTHS >=15 MM; 6) ILIAC DIAMETERS WITH A RANGE OF 8 TO 25 MM; AND 7) MORPHOLOGY SUITABLE FOR ANEURYSM REPAIR.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MIH | System, Endovascular Graft, Aortic Aneurysm Treatment | FDA class 3 | Unknown |